PE
ATRC icon

Point72 Europe’s AtriCure ATRC Stock Holding History

Point72 Europe’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20.4K Buy
+579
New +$19.9K ﹤0.01% 469

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Point72 Europe's ATRC Position: Q3 2025 in Review

Point72 Europe opened a new position in AtriCure (ATRC) in Q3 2025: 579 shares worth $20.4K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings.

223 funds tracked by Wall St. Rank hold ATRC as of Q3 2025.

  • Point72 Europe held 579 shares of AtriCure worth $20.4K as of Q3 2025.
  • AtriCure was a new Point72 Europe position in Q3 2025.
  • AtriCure made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #469 holding.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.